Grant Jerome Alan

SEC source: 0001261654-22-000006 · wf-form4_164194074309397.xml · derivative · entry 3

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,570

Underlying: Common Stock, $0.0001 par value · 23,570 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F2 · derivative.exercise_date: On January 7, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F2 · derivative.expiration_date: On January 7, 2020, the reporting person was granted restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001261654-22-000006 · wf-form4_164194074309397.xml · nonDerivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,260

SEC source: 0001261654-22-000006 · wf-form4_164194074309397.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,978

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000099 · wf-form4_163978140650059.xml · derivative · entry 3

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,880

Underlying: Common Stock, $0.0001 par value · 31,939 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 12/10/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 12/10/2021.

SEC source: 0001261654-21-000099 · wf-form4_163978140650059.xml · nonDerivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,408

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/10/2020.

SEC source: 0001261654-21-000099 · wf-form4_163978140650059.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 12/10/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

SEC source: 0001261654-21-000087 · wf-form4_163917457107049.xml · derivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,829

Underlying: Common Stock, $0.0001 par value · 79,870 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000087 · wf-form4_163917457107049.xml · derivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475,526

Underlying: Common Stock, $0.0001 par value · 149,757 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000002 · wf-form4_161057565227326.xml · derivative · entry 3

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,959

Underlying: Common Stock, $0.0001 par value · 23,569 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

SEC source: 0001261654-21-000002 · wf-form4_161057565227326.xml · nonDerivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,893

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.

SEC source: 0001261654-21-000002 · wf-form4_161057565227326.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 11

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Cash · 52,875 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the third anniversary of the grant date at the end of the performance period. The amount delivered is equal to 141% performance achievement pursuant to the terms of the award.

F9 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the third anniversary of the grant date at the end of the performance period. The amount delivered is equal to 141% performance achievement pursuant to the terms of the award.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 10

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.0001 par value · 26,072 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, which vests based on the 3-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to 141% performance achievement pursuant to the terms of the award.

F8 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, which vests based on the 3-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to 141% performance achievement pursuant to the terms of the award.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 9

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.0001 par value · 14,793 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Vesting of restricted stock units granted on 12/5/2017.

F7 · derivative.exercise_date: Vesting of restricted stock units granted on 12/5/2017.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 6

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,213

F3 · balance_after: Performance cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 5

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Performance cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 4

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,213

F2 · shares: Shares withheld to satisfy tax liability for the vesting of performance units granted on 12/5/2017.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 3

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,105

F1 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/5/2017.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 8

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,769

Underlying: Common Stock, $0.0001 par value · 179,661 shares

Expires 2023-12-10

F6 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F6 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 7

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,528

Underlying: Common Stock, $0.0001 par value · 95,819 shares

Expires 2023-12-10

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F5 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001209191-20-002726 · doc4.xml · derivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,108

Underlying: Common Stock · 146,108 shares

Expires 2022-01-07

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2021 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2021, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2021 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2021, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001209191-20-002726 · doc4.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,104

F1 · shares: One third of the restricted stock units approved by the Board of Directors shall vest on each anniversary of the grant date.

SEC source: 0001261654-20-000103 · wf-form4a_160876241248615.xml · derivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,528

Underlying: Common Stock, $0.0001 par value · 70,709 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F2 · shares: This Form 4/A does not report a new transaction. The reporting person's original Form 4 incorrectly reported these securities as Common Stock rather than restricted stock units.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on January 7, 2021.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on January 7, 2021.

F4 · balance_after: The incorrect classification described in footnote (2) above resulted in incorrect reporting of beneficial ownership of the UTI Common Stock in the original Form 4. As of the date of this Form 4/A, none of the restricted stock units has vested. The beneficial ownership of the restricted stock units has been corrected in this Form 4/A and reflects the reporting person's correct ownership as of the date of this filing.

SEC source: 0001209191-19-060989 · doc4.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,395

F1 · shares: Vesting of Performance Units granted on 12/5/2017. Shares withheld to satisfy tax liability.

SEC source: 0001209191-20-013781 · doc4a.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,318

F1 · shares: This amended Form 4 is solely to correct number of shares withheld for taxes.

SEC source: 0001209191-19-059878 · doc4.xml · derivative · entry 6

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Cash · Not disclosed shares

Expires 2019-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount delivered is equal to the maximum amount of cash that may be delivered pursuant to the award.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount delivered is equal to the maximum amount of cash that may be delivered pursuant to the award.

SEC source: 0001209191-19-059878 · doc4.xml · derivative · entry 5

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,738 shares

Expires 2019-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to the maximum number of shares that may be delivered pursuant to the award.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to the maximum number of shares that may be delivered pursuant to the award.

SEC source: 0001209191-19-059878 · doc4.xml · nonDerivative · entry 4

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,899

F3 · shares: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount delivered is equal to the maximum amount of cash that may be delivered pursuant to the award.

F4 · balance_after: Performance Cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001209191-19-059878 · doc4.xml · nonDerivative · entry 3

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount delivered is equal to the maximum amount of cash that may be delivered pursuant to the award.

F4 · balance_after: Performance Cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001209191-19-059878 · doc4.xml · nonDerivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,899

F2 · shares: Vesting of Restricted Stock Units granted on 12/5/2017. Shares withheld to satisfy tax liability.

SEC source: 0001209191-19-059878 · doc4.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,115

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to the maximum number of shares that may be delivered pursuant to the award.

SEC source: 0001209191-18-061822 · doc4.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,377

F1 · shares: Vesting of Restricted Stock Units granted on 12/5/2017. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-064550 · doc4.xml · derivative · entry 3

Grant Jerome Alan · CIK 0001723537 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064550 · doc4.xml · derivative · entry 2

Grant Jerome Alan · CIK 0001723537 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,474

Underlying: Common Stock · 55,474 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064550 · doc4.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,379

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.